Sort
64,565 grants matching “drug discovery”
Center for Systems Biology
$3,651,071Leroy E Hood · Institute For Systems Biology · P50 · FY2006 · GM
Medicinal Chemistry and Chemical Biology Core
$3,650,390Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2020 · AG
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
$3,649,220Pamela J Lein · University Of California At Davis · U54 · FY2021 · NS
CANCER CENTER SUPPORT GRANT
$3,649,220Kristiina Vuori · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2008 · CA
Pharmacokinetics and Drug Metabolism
$3,645,996Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Kentucky Center for Clinical and Translational Science
$3,645,338Philip A Kern · University Of Kentucky · UL1 · FY2016 · TR
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$3,643,319Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks
$3,641,568Paul M Thompson · University Of Southern California · U01 · FY2022 · AG
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL
$3,640,781Jiawei Han · University Of Illinois At Urbana-Champaign · U54 · FY2017 · GM
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
$3,639,604Barry Coller · Rockefeller University · UL1 · FY2020 · TR
Kentucky Center for Clinical and Translational Science
$3,632,713Philip A Kern · University Of Kentucky · UL1 · FY2018 · TR
Kentucky Center for Clinical and Translational Science
$3,632,703Philip A Kern · University Of Kentucky · UL1 · FY2017 · TR
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$3,623,079Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2024 · DA
Utah Trial Innovation Center
$3,622,562Jonathan Michael Dean · University Of Utah · U24 · FY2016 · TR
Kansas IDeA Network of Biomedical Research Excellence
$3,622,489Joan Sherar Hunt · University Of Kansas Medical Center · P20 · FY2010 · RR
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
$3,622,387Virginia M Lee · University Of Pennsylvania · U19 · FY2022 · AG
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
$3,622,387Virginia M Lee · University Of Pennsylvania · U19 · FY2023 · AG
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
$3,621,459Virginia M Lee · University Of Pennsylvania · U19 · FY2021 · AG
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
$3,621,215John Q. Trojanowski · University Of Pennsylvania · U19 · FY2019 · AG
Greater Southern California Node of the Clinical Trials Network
$3,618,060Yih-Ing Hser · University Of California Los Angeles · UG1 · FY2019 · DA
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$3,614,688Anand Swaroop · National Eye Institute · ZIA · FY2021 · EY
NHLBI CATALYZE COORDINATING CENTER SUPPORT SERVICES
$3,613,714Diana Severynse-Stevens · Research Triangle Institute · N02 · FY2025 · HL
Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration
$3,612,421Christopher Ramsden · National Institute On Aging · ZIA · FY2024 · AG
Integrative genetics of behavior with high throughput technologies
$3,612,191David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
$3,611,256John Q. Trojanowski · University Of Pennsylvania · U19 · FY2020 · AG